Big Oil Scares Off Short Sellers
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.
All Work
Chris Lange
Social Media Stocks Fend Off Short Sellers
The November 15 short interest data have been compared with the previous report. Short interest moves in these selected social media stocks were mixed for this settlement date.
Short Sellers Hike Their Bets in Major Pharma Stocks
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Major Semiconductors See Mixed Bag in Short Interest Report
The November 15 short interest data have been compared with the previous report. Short interest moves in these selected semiconductor stocks were mixed.
Short Sellers Grow More Selective on Cybersecurity Stocks
The November 15 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks were mixed.
Are Short Sellers Signaling More Optimism in Big Banks?
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected big bank stocks decreased.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively positive day for the broad U.S. markets. Each of the major averages started out the day on a negative note but as the day went on they ended up fairly…
Catabasis Wins With Early-Stage Duchenne Muscular Dystrophy Study
Catabasis Pharmaceuticals shares made a handy gain on Tuesday after the company announced early stage data from its Duchenne muscular dystrophy study.
Rocket Pharma Grounded Despite Positive FDA Update
Rocket Pharmaceuticals shares dipped on Tuesday after the company gave an update from the FDA. While the update wasn’t negative, this seems to be a case of sell the news, as the stock is…
Bristol-Myers Loses Out in Late-Stage Lung Cancer Study
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
What One Key Analyst Has to Say Ahead of the Salesforce Report
Salesforce is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday. Ahead of this report, one analyst weighed in on the stock and why it could be going higher.
Why Wedbush Is Staying Positive on Zafgen
Despite this crushing loss where we saw shares down about 41% on Monday, one analyst is still positive on the stock.
Amazon Comes Away as a Big Winner on Cyber Monday
Black Friday and Cyber Monday have come and gone, and Amazon stands to be one of the biggest winners from the kickoff of holiday shopping.
Mogu Closes in on IPO
Online fashion and lifestyle company Mogu intends to offer more than 4 million American depositary shares in an initial public offering valued up to more than $87 million.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a positive day for the broad U.S. markets. Each of the major averages tacked on at least 1.5% in the session. Crude oil made a rebound on Monday but it is still…
Why One Top Analyst Sees Nvidia Sell-Off Way Overdone With Big Upside Ahead
Nvidia has seen its shares tumble over the past two months and now that everything seems to be settling down one brokerage firm thinks that this stock could be a winner going forward.
What to Expect When Salesforce Reports on Tuesday
Salesforce is scheduled to release its most recent quarterly results after the markets close on Tuesday, and the consensus forecast calls for solid growth on the top and bottom lines.
Newell Brands Adds a New Executive to the Mix
Newell Brands shares shot up on Monday after the company announced that it would be shuffling the deck at the executive level.
Why Zafgen Shares Got Stomped
Zafgen shares were absolutely crushed on Monday after the company announced an update from the FDA.